Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline Psoriasis Area and Severity Index from week 4 to 40
Autor: | Langley, Richard G. a, Sanyal, Chiranjeev b, c, Situ, Aaron c, d, Alulis, Sarah e, Hassan, Fareen f, Peterson, Steve g, Teneralli, Rachel E. g, Lee, Jennifer e, Patel, Barkha P. c, Disher, Tim c, ∗ |
---|---|
Zdroj: | In JAAD International June 2024 15:165-167 |
Databáze: | ScienceDirect |
Externí odkaz: |